Sponsor:
Henry Ford Health System
Code:
NCT07037888
Conditions
Femoracetabular Impingement
Hip Arthroscopy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ketorolac
Control (Standard treatment)
Control (Standard treatment)
Control (Standard treatment)
Omeprazole
Brief summary:
Conditions
Femoracetabular Impingement
Hip Arthroscopy
Study ID
NCT07037888
Start date
Dec 13, 2023
Status verified date
Jun, 2026
Completion date
Dec, 2026
Anticipated
Primary completion date
Sep, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
placebo comparator: Control
active comparator: Ketorolac
Interventions
Ketorolac
Control (Standard treatment)
Control (Standard treatment)
Control (Standard treatment)
Omeprazole
Primary outcome measure
Locations
Henry Ford Health
Recruiting
Detroit, Michigan, United States, 48202
Contacts
Michael Gaudiani
mgaudia1@hfhs.orgPrincipal Investigator:
Thomas Lynch
Sponsor
Henry Ford Health System
Last update posted
Jun 30, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Henry Ford Health System on 2026-06-30.